SCIRENT was founded in 2012 with the vision of helping customers develop innovative medical drugs and devices for patients with cardiovascular diseases. Our dedicated team of experienced clinical and regulatory professionals share their enthusiasm for developing effective therapies for cardiac patients. Our profound expertise in cardiovascular therapy and diagnostics sets us apart from our competitors. Our CRO offers access to an impeccable network of dedicated trial centers in Europe and North America with extensive experience in cardiovascular studies. Our customers appreciate our lean and agile management, which generally makes our performance faster and more efficient.